These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7192217)

  • 1. Evidence for an unusual multifunctional protoreceptor in hormone action.
    Agarwal MK; Paillard J; Philippe M
    Experientia; 1980 Aug; 36(8):1010-2. PubMed ID: 7192217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical nature of mineralocorticoid receptor antagonism by progestins.
    Agarwal MK; Paillard J
    Biochem Biophys Res Commun; 1979 Jul; 89(1):77-84. PubMed ID: 573122
    [No Abstract]   [Full Text] [Related]  

  • 3. Saturable binding of [3H]-promegestone in sheep liver cytosol is not to receptors for progesterone or glucocorticoids.
    Sirett DA; Grant JK
    J Steroid Biochem; 1982 Apr; 16(4):553-5. PubMed ID: 7201050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of a glucocorticoid antagonist in cultured hepatoma cells.
    Golaz S; Beck G
    Biochem Biophys Res Commun; 1983 Feb; 110(3):719-25. PubMed ID: 6682316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the rat kidney mineralocorticoid receptor.
    Eisen LP; Harmon JM
    Endocrinology; 1986 Oct; 119(4):1419-26. PubMed ID: 3019632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor.
    Rafestin-Oblin ME; Lombes M; Couette B; Baulieu EE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):815-21. PubMed ID: 1314085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia.
    Kuhnle U; Land M; Ulick S
    J Clin Endocrinol Metab; 1986 May; 62(5):934-40. PubMed ID: 3007560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an antagonist specific receptor that does not bind mineralocorticoid agonists.
    Lazar G; Agarwal MK
    Biochem Biophys Res Commun; 1986 Jan; 134(1):261-5. PubMed ID: 3004430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane.
    Ulick S; Marver D; Adam WR; Funder JW
    Endocrinology; 1979 May; 104(5):1352-6. PubMed ID: 436780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of progesterone, R-5020 and ORG-2058 to progesterone receptor.
    Keightley DD
    Eur J Cancer (1965); 1979 May; 15(5):785-90. PubMed ID: 574453
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for an androgen-binding component in the cytosol of the human term placenta.
    Stanley RL; Milwidsky A; Besch PK; Milwidsy A
    Am J Obstet Gynecol; 1980 Apr; 136(8):1003-5. PubMed ID: 6966131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone antagonists destabilize the mineralocorticosteroid receptor.
    Couette B; Lombes M; Baulieu EE; Rafestin-Oblin ME
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):697-702. PubMed ID: 1313229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity binding of [3H]R5020 and [3H]progesterone by putative progesterone receptors in cytosol and nuclear extract of turtle oviduct.
    Ho SM; Callard IP
    Endocrinology; 1984 Jan; 114(1):70-9. PubMed ID: 6537807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid interactions with plasma membrane of decidual endometrium of the rat.
    Yunghans WN; Day RN; Schiavi SC; Desmond TJ; Morré DJ; Bruner MW
    Biochem Int; 1990; 21(2):387-95. PubMed ID: 2403374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone, 5 alpha-dihydroprogesterone and R5020 binding in female rat anterior pituitary.
    Schenborn ET; Karavolas HJ
    J Steroid Biochem; 1981 Jun; 14(6):523-31. PubMed ID: 7195444
    [No Abstract]   [Full Text] [Related]  

  • 16. The endocrine background of human renal cell carcinoma. III. Role of inhibitors of R 5020 binding in tumour cytosol.
    Bojar H; Maar K; Staib W
    Urol Int; 1979; 34(5):321-9. PubMed ID: 573929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of progesterone and R5020 binding in endometrium, ovary, pituitary, and hypothalamus.
    Jacobs BR; Smith RG
    Fertil Steril; 1981 Apr; 35(4):438-41. PubMed ID: 7194194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gluco- and mineralocorticoid receptors in human liver and kidney.
    Paillard J; Baviera E; Agarwal MK
    Biochem Med; 1980 Oct; 24(2):201-9. PubMed ID: 6257236
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interaction of pregna-D'-pentaranes--pentacyclic derivatives of progesterone--with gestagen-binding sites of uterine cytosol].
    Fanchenko ND; Kamernitskiĭ AV; Minina LS; Levina IS; Alekseeva ML
    Biull Eksp Biol Med; 1988 Jun; 105(6):679-81. PubMed ID: 3390587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupancy of aldosterone binding sites in rat kidney cytosol.
    Warnock DG; Edelman IS
    Mol Cell Endocrinol; 1978 Nov; 12(2):221-33. PubMed ID: 215476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.